Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEETINGS - Integrating the Healthcare Enterprise (IHE) Portable Data for Imaging (PDI) Demonstration 2005 (US) November - December 2005:

This article was originally published in Clinica

Executive Summary

The Radiological Society of North America (RSNA) will host the Integrating the Healthcare Enterprise (IHE) Portable Data for Imaging (PDI) Demonstration 2005 at its 91st Scientific Assembly and Annual Meeting on November 28-December 2, at McCormick Place, Chicago. Vendors will participate in the demonstration of reliable interchange of patient records on CD - including images, evidence objects and diagnostic reports - for import, storage, display and printing. For details and to register, visit: www.ihe.net/Participation/index.cfm#workshop

You may also be interested in...



Interview: Novartis's Big Hopes For Beovu

After a strong start in the US, Novartis is now ready to take on Bayer's wet age-related macular degeneration blockbuster Eylea in Europe.

Flu Vaccine Leader Sanofi Joins Fight Against COVID-19

As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.

Sobi Reaps Benefits From Acquisitions, Commercial Focus

Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.

  

Topics

UsernamePublicRestriction

Register

MT055813

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel